Literature DB >> 10918599

Identification of E2F-3B, an alternative form of E2F-3 lacking a conserved N-terminal region.

Y He1, M K Armanious, M J Thomas, W D Cress.   

Abstract

We have identified a novel form of the full-length E2F-3 protein that we term E2F-3B. In contrast to full-length E2F-3, which is expressed only at the G1/S boundary, E2F-3B is detected throughout the cell cycle with peak levels in GO where it is associated with Rb. Transfection and in vitro translation experiments demonstrate that a protein identical to E2F-3B in size and iso-electric point is produced from the E2F-3 mRNA via the use of an alternative translational start site. This alternative initiation codon was mapped by mutagenesis to codon 102, an ACG codon. Mutation of the ACG codon at position 102 abolished E2F-3B expression, whereas the conversion of ACG 102 to a consensus ATG led to the expression of a protein indistinguishable from E2F-3B. Given these results, E2F-3B is missing 101 N-terminal amino acids relative to full-length E2F-3. This region includes a moderately conserved sequence of unknown function that is present only in the growth-promoting E2F family members, including E2F-1, 2 and full-length E2F-3. These observations make E2F-3B the first example of an E2F gene giving rise to two different protein species and also suggest that E2F-3 and E2F-3B may have opposing roles in cell cycle control.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10918599     DOI: 10.1038/sj.onc.1203682

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  35 in total

1.  Expression of the three human major histocompatibility complex class II isotypes exhibits a differential dependence on the transcription factor RFXAP.

Authors:  M Peretti; J Villard; E Barras; M Zufferey; W Reith
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

2.  The role of E2F4 in adipogenesis is independent of its cell cycle regulatory activity.

Authors:  Rebecca L Landsberg; Julia E Sero; Paul S Danielian; Tina L Yuan; Eunice Y Lee; Jacqueline A Lees
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-25       Impact factor: 11.205

3.  A role for E2F6 in distinguishing G1/S- and G2/M-specific transcription.

Authors:  Paloma H Giangrande; Wencheng Zhu; Susanne Schlisio; Xin Sun; Seiichi Mori; Stefan Gaubatz; Joseph R Nevins
Journal:  Genes Dev       Date:  2004-12-01       Impact factor: 11.361

4.  Distinctions in the specificity of E2F function revealed by gene expression signatures.

Authors:  Esther P Black; Timothy Hallstrom; Holly K Dressman; Mike West; Joseph R Nevins
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-25       Impact factor: 11.205

5.  Inactivation of the Rb pathway and overexpression of both isoforms of E2F3 are obligate events in bladder tumours with 6p22 amplification.

Authors:  C D Hurst; D C Tomlinson; S V Williams; F M Platt; M A Knowles
Journal:  Oncogene       Date:  2007-11-26       Impact factor: 9.867

6.  RhoBTB2 (DBC2) is a mitotic E2F1 target gene with a novel role in apoptosis.

Authors:  Scott N Freeman; Yihong Ma; W Douglas Cress
Journal:  J Biol Chem       Date:  2007-11-26       Impact factor: 5.157

7.  Unique requirement for Rb/E2F3 in neuronal migration: evidence for cell cycle-independent functions.

Authors:  Kelly A McClellan; Vladimir A Ruzhynsky; David N Douda; Jacqueline L Vanderluit; Kerry L Ferguson; Danian Chen; Rod Bremner; David S Park; Gustavo Leone; Ruth S Slack
Journal:  Mol Cell Biol       Date:  2007-04-23       Impact factor: 4.272

8.  E2f3b plays an essential role in myogenic differentiation through isoform-specific gene regulation.

Authors:  Patrik Asp; Diego Acosta-Alvear; Mary Tsikitis; Chris van Oevelen; Brian David Dynlacht
Journal:  Genes Dev       Date:  2009-01-01       Impact factor: 11.361

9.  Transcription Factor E2F3a in Nucleus Accumbens Affects Cocaine Action via Transcription and Alternative Splicing.

Authors:  Hannah M Cates; Elizabeth A Heller; Casey K Lardner; Immanuel Purushothaman; Catherine J Peña; Deena M Walker; Michael E Cahill; Rachael L Neve; Li Shen; Rosemary C Bagot; Eric J Nestler
Journal:  Biol Psychiatry       Date:  2017-12-05       Impact factor: 13.382

10.  E2f3a and E2f3b make overlapping but different contributions to total E2f3 activity.

Authors:  P S Danielian; L B Friesenhahn; A M Faust; J C West; A M Caron; R T Bronson; J A Lees
Journal:  Oncogene       Date:  2008-07-28       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.